Urothelial Cancer

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)

Recruiting
  • Urothelial Cancer
  • Nivolumab
  • +4 more
  • Birmingham, Alabama
  • +196 more
Jan 17, 2023

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Stanford, California
  • +15 more
Dec 21, 2022

Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),

Active, not recruiting
  • Carcinoma, Transitional Cell
  • +6 more
  • enfortumab vedotin (EV)
  • +4 more
  • Anchorage, Alaska
  • +105 more
Dec 19, 2022

Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)

Active, not recruiting
  • Urothelial Cancer
  • MEDI4736 (Durvalumab)
  • +4 more
  • Los Angeles, California
  • +221 more
Nov 2, 2022

Urothelial Cancer Trial in Worldwide (Erdafitinib, Vinflunine, Docetaxel)

Recruiting
  • Urothelial Cancer
  • Anchorage, Alaska
  • +414 more
Jul 14, 2022

A Genotype-Phenotype Urothelial Cancer Registry

Recruiting
  • Urothelial Cancer
  • +3 more
  • saliva sample and questionaire
  • saliva sample, questionaire
  • Basking Ridge, New Jersey
  • +3 more
Jun 2, 2022

Urothelial Cancer, Metastatic Solid Tumor Trial in New York (Colchicine)

Recruiting
  • Urothelial Cancer
  • Metastatic Solid Tumor
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 5, 2022

Urothelial Cancer Trial in Worldwide (TKI258)

Completed
  • Urothelial Cancer
  • La Jolla, California
  • +25 more
Dec 11, 2020